Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy.
Pagotto S, Simeone P, Brocco D, Catitti G, De Bellis D, Vespa S, Di Pietro N, Marinelli L, Di Stefano A, Veschi S, De Lellis L, Verginelli F, Kaitsas F, Iezzi M, Pandolfi A, Visone R, Tinari N, Caruana I, Di Ianni M, Cama A, Lanuti P, Florio R. Pagotto S, et al. Among authors: di stefano a, di pietro n, di ianni m. Cancers (Basel). 2023 Feb 7;15(4):1052. doi: 10.3390/cancers15041052. Cancers (Basel). 2023. PMID: 36831396 Free PMC article. Review.
Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents.
Gouleni N, Di Rienzo A, Yılmaz A, Selvitopi H, Arslan ME, Mardinoglu A, Turkez H, Di Stefano A, Vassiliou S, Cacciatore I. Gouleni N, et al. Among authors: di stefano a, di rienzo a. RSC Med Chem. 2023 Sep 21;14(11):2315-2326. doi: 10.1039/d3md00308f. eCollection 2023 Nov 15. RSC Med Chem. 2023. PMID: 38020070 Free PMC article.
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Picca A, Touat M, Belin L, Gourmelon C, Harlay V, Cuzzubbo S, Cohen-Jonathan Moyal E, Bronnimann C, Di Stefano AL, Laurent I, Lerond J, Carpentier C, Bielle F, Ducray F, Dehais C; POLA Network. Picca A, et al. Among authors: di stefano al. Eur J Cancer. 2024 May;202:114034. doi: 10.1016/j.ejca.2024.114034. Epub 2024 Mar 22. Eur J Cancer. 2024. PMID: 38537315 Clinical Trial.
Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling.
Morelli M, Lessi F, Franceschi S, Ferri G, Giacomarra M, Menicagli M, Gambacciani C, Pieri F, Pasqualetti F, Montemurro N, Aretini P, Santonocito OS, Di Stefano AL, Mazzanti CM. Morelli M, et al. Among authors: di stefano al. Cells. 2024 Mar 11;13(6):487. doi: 10.3390/cells13060487. Cells. 2024. PMID: 38534332 Free PMC article.
Integrated proteogenomic characterization of glioblastoma evolution.
Kim KH, Migliozzi S, Koo H, Hong JH, Park SM, Kim S, Kwon HJ, Ha S, Garofano L, Oh YT, D'Angelo F, Kim CI, Kim S, Lee JY, Kim J, Hong J, Jang EH, Mathon B, Di Stefano AL, Bielle F, Laurenge A, Nesvizhskii AI, Hur EM, Yin J, Shi B, Kim Y, Moon KS, Kwon JT, Lee SH, Lee SH, Gwak HS, Lasorella A, Yoo H, Sanson M, Sa JK, Park CK, Nam DH, Iavarone A, Park JB. Kim KH, et al. Among authors: di stefano al. Cancer Cell. 2024 Mar 11;42(3):358-377.e8. doi: 10.1016/j.ccell.2023.12.015. Epub 2024 Jan 11. Cancer Cell. 2024. PMID: 38215747
683 results